In particular, the specific detection of CLL-1 expression in CD34 + CD38- AML cells after chemotherapy in AML patients who achieved complete remission highlights its prognostic value over conventional MRD detection methods [9, 33, 46]. This evidence concerns the gene CD38 and acute myeloid leukemia.